A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents with Uncontrolled Asthma

Trial Identifier:	D2210C00029
Sponsor:	AstraZeneca
NCTID::	NCT02902809
Start Date:	November 2016
Primary Completion Date:	January 2018
Study Completion Date:	January 2018
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Chuo-ku, Japan, 103-0027
Japan	Itabashi-ku, Japan, 173-8610
Japan	Yokohama-shi, Japan, 236-0004

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.